A historic shift in Canadian drug policy has taken place, as the regulators permit the availability of psilocybin mushrooms for therapeutic purposes. Until now, these substances were strictly restricted, but a increasing body of evidence suggests they could offer relief for emotional issues like anxiety. This development represents a major step tow